In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
- InMed does not grow cannabis. We biosynthesize the compounds in a lab.
- InMed products do not contain THC.
- InMed products are applied topically.
In this video, InMed CEO Eric A. Adams talks about how InMed is differentiated from competitors.
At the 12th World Congress on Itch (WCI), held in Miami on November 5-7, 2023, InMed’s Senior VP, Clinical and Regulatory Affairs, Alexandra Mancini presented
InMed’s INM-901 is a drug candidate being developed as a potential treatment for Alzheimer’s disease. Promising early studies demonstrate INM-901’s neuroprotective effects and an ability
Jerry Griffin, VP of Sales and Marketing at BayMedica, InMed’s subsidiary, joins this live panel discussion “Transforming the CPG Landscape: Why Rare Cannabinoids Ingredients are
© Copyright 2024 InMed Pharmaceuticals Inc.
"*" indicates required fields